Axogen

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Axogen and other ETFs, options, and stocks.

About AXGN

Axogen, Inc. engages in the development and marketing of surgical solutions for peripheral nerve regeneration and repair. It provides products and educational resources to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. 

CEO
Michael D. Dale
CEOMichael D. Dale
Employees
622
Employees622
Headquarters
Alachua, Florida
HeadquartersAlachua, Florida
Founded
1977
Founded1977
Employees
622
Employees622

AXGN Key Statistics

Market cap
2.43B
Market cap2.43B
Price-Earnings ratio
-66.73
Price-Earnings ratio-66.73
Dividend yield
Dividend yield
Average volume
1.45M
Average volume1.45M
High today
$45.40
High today$45.40
Low today
$44.03
Low today$44.03
Open price
$44.87
Open price$44.87
Volume
307.40K
Volume307.40K
52 Week high
$52.91
52 Week high$52.91
52 Week low
$15.27
52 Week low$15.27

Stock Snapshot

The current Axogen(AXGN) stock price is $45.28, with a market capitalization of 2.43B. The stock trades at a price-to-earnings (P/E) ratio of -66.73.

On 2026-09-16, Axogen(AXGN) stock moved within a range of $44.03 to $45.40. With shares now at $45.28, the stock is trading +2.8% above its intraday low and -0.3% below the session's peak.

Trading volume for Axogen(AXGN) stock has reached 307.4K, versus its average volume of 1.45M.

Over the past 52 weeks, Axogen(AXGN) stock has traded between a high of $52.91 and a low of $15.27.

Over the past 52 weeks, Axogen(AXGN) stock has traded between a high of $52.91 and a low of $15.27.

AXGN News

Simply Wall St 3d
Is Axogen A Bargain Following Its US$208.7m Equity Raise? - simplywall.st

...

Is Axogen A Bargain Following Its US$208.7m Equity Raise? - simplywall.st
Benzinga 6d
Axogen Raises $200 Million to Fund BioCircuit Buyout Focused on Sutureless Nerve Repair

Axogen Inc. (NASDAQ:AXGN) on Thursday agreed to acquire a privately held medical device manufacturer, BioCircuit Technologies Inc., for $200 million in cash. T...

Axogen Raises $200 Million to Fund BioCircuit Buyout Focused on Sutureless Nerve Repair
Seeking Alpha 6d
Axogen to buy BioCircuit Technologies for $200M

Axogen (AXGN) has agreed to acquire privately held medical-device company BioCircuit Technologies for $200M in cash, expanding its portfolio of surgical solutio...

Axogen to buy BioCircuit Technologies for $200M

Analyst ratings

91%

of 11 ratings
Buy
90.9%
Hold
9.1%
Sell
0%

More AXGN News

TipRanks 6d
AxoGen to Acquire BioCircuit, Expanding Nerve Repair Portfolio

AxoGen ( (AXGN) ) has shared an update. On September 9–10, 2026, Axogen agreed to acquire BioCircuit Technologies for $200 million in cash, with BioCircuit to...

Nasdaq 6d
Axogen To Acquire BioCircuit Technologies

(RTTNews) - Axogen (AXGN) has entered into a definitive agreement to acquire BioCircuit Technologies, a privately held medical device company and developer of N...

Axogen To Acquire BioCircuit Technologies

People also own

Based on the portfolios of people who own AXGN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.